Is Accolade Stock a Good Investment?
Accolade Investment Advice | ACCD |
- Examine Accolade's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Accolade's leadership team and their track record. Good management can help Accolade navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Technology space and any emerging trends that could impact Accolade's business and its evolving consumer preferences.
- Compare Accolade's performance and market position to its competitors. Analyze how Accolade is positioned in terms of product offerings, innovation, and market share.
- Check if Accolade pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Accolade's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Accolade stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Accolade is a good investment.
Sell | Buy |
Cautious Hold
Market Performance | Very Weak | Details | |
Volatility | Slightly risky | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | High | Details | |
Economic Sensitivity | Actively responds to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Accolade Stock
Researching Accolade's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 84.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.73. Some equities with similar Price to Book (P/B) outperform the market in the long run. Accolade has Price/Earnings To Growth (PEG) ratio of 1.91. The entity recorded a loss per share of 1.02. The firm had not issued any dividends in recent years.
To determine if Accolade is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Accolade's research are outlined below:
| Accolade generated a negative expected return over the last 90 days | |
| Accolade has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 414.29 M. Net Loss for the year was (99.81 M) with profit before overhead, payroll, taxes, and interest of 165.26 M. | |
| Accolade currently holds about 330.63 M in cash with (16.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.6, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Accolade has a poor financial position based on the latest SEC disclosures | |
| Over 84.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from thelincolnianonline.com: Accolade, Inc. Sees Large Decline in Short Interest |
Accolade Quarterly Liabilities And Stockholders Equity |
|
Accolade uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Accolade. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Accolade's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 25th of April 2024 Upcoming Quarterly Report | View | |
| 4th of July 2024 Next Financial Report | View | |
| 29th of February 2024 Next Fiscal Quarter End | View | |
| 25th of April 2024 Next Fiscal Year End | View | |
| 30th of November 2023 Last Quarter Report | View | |
| 28th of February 2023 Last Financial Announcement | View |
Earnings surprises can significantly impact Accolade's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Accolade's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-04-25 | 2024-02-29 | -0.07 | -0.1 | -0.03 | 42 | ||
2020-10-14 | 2020-08-31 | -0.4 | -0.47 | -0.07 | 17 | ||
2023-06-29 | 2023-05-31 | -0.62 | -0.52 | 0.1 | 16 | ||
2023-10-04 | 2023-08-31 | -0.54 | -0.43 | 0.11 | 20 | ||
2021-05-05 | 2021-02-28 | -0.1 | -0.22 | -0.12 | 120 | ||
2024-06-27 | 2024-05-31 | -0.48 | -0.35 | 0.13 | 27 | ||
2024-10-08 | 2024-08-31 | -0.44 | -0.3 | 0.14 | 31 | ||
2022-04-28 | 2022-02-28 | -0.36 | -0.51 | -0.15 | 41 |
Know Accolade's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Accolade is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Accolade backward and forwards among themselves. Accolade's institutional investor refers to the entity that pools money to purchase Accolade's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Geode Capital Management, Llc | 2024-09-30 | 1.8 M | Clearline Capital Lp | 2024-09-30 | 1.5 M | Dimensional Fund Advisors, Inc. | 2024-09-30 | 1.5 M | Prosight Management, Lp | 2024-06-30 | 1.5 M | D. E. Shaw & Co Lp | 2024-09-30 | 1.3 M | Fairman Group Llc | 2024-09-30 | 1.1 M | Jane Street Group Llc | 2024-06-30 | 1 M | Whetstone Capital Advisors, Llc | 2024-09-30 | 997.9 K | Goldman Sachs Group Inc | 2024-06-30 | 776.8 K | Blackrock Inc | 2024-06-30 | 6.2 M | Ark Investment Management Llc | 2024-09-30 | 5.4 M |
Accolade's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 310.87 M.Market Cap |
|
Accolade's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.29) | (0.30) | |
| Return On Capital Employed | (0.17) | (0.18) | |
| Return On Assets | (0.13) | (0.13) | |
| Return On Equity | (0.22) | (0.21) |
Determining Accolade's profitability involves analyzing its financial statements and using various financial metrics to determine if Accolade is a good buy. For example, gross profit margin measures Accolade's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Accolade's profitability and make more informed investment decisions.
Please note, the presentation of Accolade's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Accolade's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Accolade's management manipulating its earnings.
Evaluate Accolade's management efficiency
Accolade has return on total asset (ROA) of (0.0727) % which means that it has lost $0.0727 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1861) %, meaning that it created substantial loss on money invested by shareholders. Accolade's management efficiency ratios could be used to measure how well Accolade manages its routine affairs as well as how well it operates its assets and liabilities. As of November 30, 2024, Return On Tangible Assets is expected to decline to -0.3. In addition to that, Return On Capital Employed is expected to decline to -0.18. At present, Accolade's Asset Turnover is projected to slightly decrease based on the last few years of reporting.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 5.95 | 3.07 | |
| Tangible Book Value Per Share | 0.02 | 0.02 | |
| Enterprise Value Over EBITDA | (11.57) | (12.15) | |
| Price Book Value Ratio | 1.72 | 1.81 | |
| Enterprise Value Multiple | (11.57) | (12.15) | |
| Price Fair Value | 1.72 | 1.81 | |
| Enterprise Value | 823.7 M | 422.7 M |
Accolade showcases strong leadership that adapts to market changes and drives innovation. Our analysis explores how this adaptability affects the stock's investment appeal.
Beta 2.016 |
Basic technical analysis of Accolade Stock
As of the 30th of November, Accolade shows the risk adjusted performance of (0.02), and Mean Deviation of 2.3. Accolade technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Accolade information ratio, potential upside, and the relationship between the standard deviation and maximum drawdown to decide if Accolade is priced correctly, providing market reflects its regular price of 3.86 per share. Given that Accolade has information ratio of (0.08), we suggest you to validate Accolade's prevailing market performance to make sure the company can sustain itself at a future point.Accolade's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Accolade insiders, such as employees or executives, is commonly permitted as long as it does not rely on Accolade's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Accolade insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Accolade's Outstanding Corporate Bonds
Accolade issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Accolade uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Accolade bonds can be classified according to their maturity, which is the date when Accolade has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View |
Understand Accolade's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Accolade's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | (0.05) | |||
| Mean Deviation | 2.3 | |||
| Coefficient Of Variation | (3,136) | |||
| Standard Deviation | 2.92 | |||
| Variance | 8.55 | |||
| Information Ratio | (0.08) | |||
| Jensen Alpha | (0.31) | |||
| Total Risk Alpha | (0.59) | |||
| Treynor Ratio | (0.06) | |||
| Maximum Drawdown | 14.05 | |||
| Value At Risk | (4.53) | |||
| Potential Upside | 5.87 | |||
| Skewness | 0.4802 | |||
| Kurtosis | 0.221 |
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | (0.05) | |||
| Mean Deviation | 2.3 | |||
| Coefficient Of Variation | (3,136) | |||
| Standard Deviation | 2.92 | |||
| Variance | 8.55 | |||
| Information Ratio | (0.08) | |||
| Jensen Alpha | (0.31) | |||
| Total Risk Alpha | (0.59) | |||
| Treynor Ratio | (0.06) | |||
| Maximum Drawdown | 14.05 | |||
| Value At Risk | (4.53) | |||
| Potential Upside | 5.87 | |||
| Skewness | 0.4802 | |||
| Kurtosis | 0.221 |
Consider Accolade's intraday indicators
Accolade intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Accolade stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Accolade Corporate Filings
F4 | 26th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
8K | 8th of October 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 7th of October 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
Accolade Stock media impact
Far too much social signal, news, headlines, and media speculation about Accolade that are available to investors today. That information is available publicly through Accolade media outlets and privately through word of mouth or via Accolade internal channels. However, regardless of the origin, that massive amount of Accolade data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Accolade news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Accolade relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Accolade's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Accolade alpha.
Accolade Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Accolade can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Accolade Corporate Management
| Richard JD | General VP | Profile | |
| Robert Cavanaugh | President | Profile | |
| Michael Hilton | Chief Officer | Profile | |
| James MD | Senior Officer | Profile | |
| Kristin Herrera | Executive Business | Profile | |
| Colin McHugh | Chief Officer | Profile | |
| Jennifer Hanson | Executive Officer | Profile |
Already Invested in Accolade?
The danger of trading Accolade is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Accolade is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Accolade. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Accolade is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Accolade is a strong investment it is important to analyze Accolade's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Accolade's future performance. For an informed investment choice regarding Accolade Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Accolade. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. For information on how to trade Accolade Stock refer to our How to Trade Accolade Stock guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Accolade. If investors know Accolade will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Accolade listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.02) | Revenue Per Share 5.706 | Quarterly Revenue Growth 0.098 | Return On Assets (0.07) | Return On Equity (0.19) |
The market value of Accolade is measured differently than its book value, which is the value of Accolade that is recorded on the company's balance sheet. Investors also form their own opinion of Accolade's value that differs from its market value or its book value, called intrinsic value, which is Accolade's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Accolade's market value can be influenced by many factors that don't directly affect Accolade's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Accolade's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Accolade is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Accolade's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.